register

News - MedTech & Diagnostics

Vantive opens purpose-built hub for sustainable reuse of dialysis machines

Health Industry Hub | August 12, 2026 |

Vantive has opened a purpose-built facility for the sustainable refurbishment and reuse of home dialysis machines, as part of its new national Central Service Hub in Sydney.

The new facility doubles the footprint of Vantive’s previous site. It has been designed to make the refurbishment and return of devices to the field more efficient, with the company expecting to reuse more than 90% of home dialysis machines reaching the end of their initial use.

Vantive expects the redesigned workflow and introduction of new technology to increase the productivity of its home dialysis machine refurbishment operations by 35%. Once returned from the field, the machines undergo a series of safety and quality processes, including decontamination, sterilisation, recalibration and testing, before being prepared for reuse. The facility has been physically designed to support this workflow.

“This investment in Australian dialysis care reflects Vantive’s mission to extend lives and expand possibilities,” said Matthew Bain, General Manager, Vantive Australia and New Zealand. “The new national Central Service Hub will create greater capacity to support customers, clinicians and the patients they serve, while strengthening the dialysis service infrastructure available across Australia.”

The new hub also represents an expansion of Vantive’s technical services capabilities, bringing several previously separate functions together under one roof. The facility is the company’s national centre for testing and calibrating devices entering Australia before they are deployed to hospitals and patients. It also manages repairs, maintenance and recalibration throughout the life of devices in the field.

Alongside these technical services, the hub now houses Vantive’s connected care capabilities, supporting the growing number of connected and remote patient management devices used in healthcare. Teams at the site can remotely monitor devices in the field, update software and manage connectivity without requiring every intervention to take place on site.

The consolidation of these functions was part of the rationale for establishing the new Seven Hills facility. Vantive’s technical services team had previously operated alongside Baxter’s office and technical service operations. Moving into a standalone facility created an opportunity not only to separate the operations physically, but to redesign the site around the evolving needs of the business.

That redesign has placed sustainability alongside technical performance and patient safety as a core consideration in how devices are managed throughout their lifecycle.

“As we continue to work with clinicians to increase access to home dialysis care and new innovation in vital organ therapies, we see this Central Service Hub as an investment in the future of dialysis care in Australia,” Bain added.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


Digital & Innovation

Health sector faces new privacy obligations

Health sector faces new privacy obligations

Health Industry Hub | September 11, 2026 |

Healthcare organisations must update their privacy policies by 10 December if they use artificial intelligence (AI) or a computer program […]

More


News - Pharmaceuticals

TGA approves new antibiotic but AMR blind spot remains a critical concern

TGA approves new antibiotic but AMR blind spot remains a critical concern

Health Industry Hub | September 11, 2026 |

The Therapeutic Goods Administration (TGA) has approved a new antibiotic for the treatment of carbapenem-resistant Gram-negative bacterial infections. Developed by […]

More


News - MedTech & Diagnostics

BCAL Diagnostics rejects merger speculation

BCAL Diagnostics rejects merger speculation

Health Industry Hub | September 11, 2026 |

ASX-listed BCAL Diagnostics has moved to quash speculation of a potential three-way merger involving Genetic Signatures and Microba Life Sciences, […]

More


News - Pharmaceuticals

Australia backs infectious disease innovation as US funding faces more cuts

Australia backs infectious disease innovation as US funding faces more cuts

Health Industry Hub | September 11, 2026 |

Biointelect Venturer, a national incubator supporting infectious disease innovation, will open its second funding round later this month, with AUD […]

More


This content is copyright protected. Please subscribe to gain access.